Kinnevik AB (publ)

Q4 2024 13F Holdings

  • Location
    stockholm, V7
  • Num holdings

    1

  • Value ($000)

    $80,482

  • Date Filed
    01/23/2025
  • Form type
    13F-HR
  • CIK
    0001766574
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
RXRX
RXRX

Recursion Pharmaceuticals, Inc.

CL A
75629V104
$80.48M
100 %

11,905,668

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 1 of 1